Clinuvel Pharmaceuticals LimitedASX: CUV

New CUV105 vitiligo cases presented to EADV

· Issued by Clinuvel Pharmaceuticals Limited via ASX

Filed with ASX ·

On 6ix: 6ix.com/news/new-cuv105-vitiligo-cases-presented-to-eadv

Watch Clinuvel Pharmaceuticals' latest callClinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call · Replay · Aug 27Read the transcript of Clinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call

A S X A N N O U N C E M E N T ASX: CUV | Nasdaq: CUVL | Börse Frankfurt: UR9 ASX Announcement PAGE 1 OF 4 SCENESSE® response in vitiligo: new cases from the CUV105 trial presented to EADV Melbourne / Singapore – 1 October 2026 – CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq:...

View Attachment

6ix hasn’t read this filing yet.

Clinuvel Pharmaceuticals Limited on 6ix

Story so far

Earlier from Clinuvel Pharmaceuticals

Later from Clinuvel Pharmaceuticals

All Clinuvel Pharmaceuticals news releases